AbCellera Biologics Inc. - SIC # 2836 - BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES

Ticker Exchange SIC # Website Latest Ticker
ABCL Nasdaq 2836 www.abcellera.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for AbCellera Biologics Inc.

JonesResearch Initiates Coverage of AbCellera Biologics Inc. (ABCL) - Apr 20th, 2026 3:29 pm
AbCellera to Highlight Phase 1 Clinical Data for ABCL635 During Upcoming First Quarter 2026 Earnings Call - Apr 20th, 2026 7:00 am
Is Jones Trading’s New Coverage of AbCellera (ABCL) Reframing Its Clinical-Stage Platform Narrative? - Apr 14th, 2026 7:06 am
AbCellera Biologics (ABCL) Committed to Leverage Differentiated Technology for Drug Discovery - Apr 13th, 2026 11:59 pm
AbCellera (ABCL): Among the Stocks That Could 10x Over the Next 5 Years - Apr 2nd, 2026 7:50 am
AbCellera to Report First Quarter 2026 Financial Results on May 11, 2026 - Apr 1st, 2026 2:05 pm
3 Penny Stocks With Market Caps Under $19B To Watch - Apr 1st, 2026 6:05 am
AbCellera Biologics Eyes Integrated Biotech Shift; ABCL635 Phase II Data Due in Q3 at Forum - Mar 18th, 2026 5:20 pm
AbCellera Biologics Pivots to Pipeline as ABCL635 Phase II Hot Flash Data Nears, Exec Says - Mar 4th, 2026 9:50 am
Why AbCellera (ABCL) Is Up 11.5% After Narrowing Losses And Expanding ESOP Share Capacity – And What's Next - Feb 26th, 2026 7:09 pm
AbCellera Biologics (ABCL) Pivots to Clinical Stage as 2025 Revenue Hits $75M - Feb 26th, 2026 12:28 pm
AbCellera Biologics Inc. Q4 2025 Earnings Call Summary - Feb 25th, 2026 6:02 pm
AbCellera Biologics Inc (ABCL) Q4 2025 Earnings Call Highlights: Navigating Growth Amidst Challenges - Feb 24th, 2026 10:00 pm
AbCellera Biologics Inc. (ABCL) Reports Q4 Loss, Tops Revenue Estimates - Feb 24th, 2026 7:55 pm
AbCellera Biologics Q4 Earnings Call Highlights - Feb 24th, 2026 4:26 pm
AbCellera Reports Full Year 2025 Business Results - Feb 24th, 2026 2:05 pm
3 New Stocks SoftBank Is Betting Big on in 2026 - Feb 19th, 2026 5:30 am
SoftBank Adds TwentyOne Capital, Exits Nvidia in Q4 Portfolio Shift - Feb 18th, 2026 7:43 am
Forget AI Stocks: This Pharma Giant Is Using AI to Dominate Drug Discovery - Feb 15th, 2026 4:00 pm
3 Promising Penny Stocks With At Least $600M Market Cap - Feb 12th, 2026 5:04 am